reader comments 31 with 29 posters participating Share this story The new bivalent COVID-19 booster spurred neutralizing antibody levels that were fourfold higher against the omicron subvariants BA.4/BA.5 in older adults than those seen after the original booster, Pfizer reported Friday. The new data may help calm concerns about whether the updated booster is an ..
Enlarge / An Army veteran waits the recommended 15 minutes to see if he will have any adverse reactions after receiving his second COVID-19 booster shot at Edward Hines Jr. VA Hospital on April 1, 2022, in Hines, Illinois. reader comments 110 with 49 posters participating Share this story As expected, the Food and Drug ..
reader comments 155 with 88 posters participating Share this story The omicron coronavirus subvariant BA.5 is hurtling toward complete domination in the US, now accounting for an estimated 78 percent of the country’s cases—which are also on the rise. The breakneck takeover is stunning, with BA.5 showing a significant growth advantage over all other lineages ..
reader comments 65 with 52 posters participating Share this story The swift rise of omicron subvariant BA.5—with its increased immune-evading abilities and demonstrable growth advantage—has federal officials on edge. In a flurry of activity late Monday and early Tuesday, officials doubled down on pandemic measures, renewed calls for vigilance, and are considering expanding eligibility of ..
Enlarge / MUMBAI, INDIA JUNE 7: A health worker collects swab samples of a citizen for Covid-19 test after cases are on the rise in the city, at TMC’s C.R. Wadia Hospital testing centre, in Thane, on June 7, 2022 in Mumbai, India. reader comments 109 with 71 posters participating Share this story As the ..
Enlarge / Dr. Peter Marks, director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, testifies during a Senate Health, Education, Labor, and Pensions Committee hearing on the federal coronavirus response on Capitol Hill on March 18, 2021, in Washington, DC. reader comments 105 with 69 posters participating Share this ..
Enlarge / A COVID-19 testing tent stands in Times Square on April 27, 2022, in New York City. reader comments 68 with 49 posters participating Share this story Omicron coronavirus subvariants BA.4 and BA.5 are now accounting for an estimated 35 percent of US cases, according to the Centers for Disease Control and Prevention. The ..
Enlarge / Members of the public queue outside a pharmacy to receive COVID-19 antigen tests in Paris on January 6, 2022. reader comments 121 with 86 posters participating Share this story Omicron subvariants BA.4 and BA.5 are on the rise in the European Union, spurring officials there to warn that a surge of COVID-19 cases ..
Enlarge / A person holds a positive SARS-CoV-2 rapid test on February 17, 2022 in Berlin, Germany. reader comments 97 with 57 posters participating Share this story Omicron subvariant BA.2.12.1 has overtaken BA.2 as the dominant version of the pandemic coronavirus in the US, now accounting for an estimated 59 percent of cases nationwide. But ..
Enlarge / A COVID-19 testing tent stands in Times Square on April 27, 2022, in New York City. reader comments 233 with 115 posters participating Share this story Enduring an initial omicron infection may not spare you from omicron’s subvariants, according to preliminary data from South Africa. The country is currently at the start of ..